Dallah Healthcare Company (TADAWUL: 4004)
Saudi Arabia
· Delayed Price · Currency is SAR 151.80
0.00 (0.00%)
Nov 20, 2024, 3:14 PM AST
Dallah Healthcare Company Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 3,203 | 2,943 | 2,488 | 2,105 | 1,318 | 1,252 | Upgrade
|
| Revenue Growth (YoY) | 13.15% | 18.28% | 18.18% | 59.69% | 5.28% | 6.02% | Upgrade
|
| Cost of Revenue | 2,050 | 1,921 | 1,631 | 1,361 | 875.03 | 811.32 | Upgrade
|
| Gross Profit | 1,153 | 1,021 | 857.34 | 744.2 | 443.22 | 440.77 | Upgrade
|
| Selling, General & Admin | 561.29 | 519.68 | 437.06 | 399.18 | 300.47 | 278.52 | Upgrade
|
| Other Operating Expenses | -24.65 | -33.87 | -4.06 | -33.46 | -21.71 | - | Upgrade
|
| Operating Expenses | 566.67 | 515.07 | 439.05 | 382.82 | 285.06 | 286.38 | Upgrade
|
| Operating Income | 586.15 | 506.4 | 418.29 | 361.38 | 158.17 | 154.39 | Upgrade
|
| Interest Expense | -105.25 | -104.14 | -70.49 | -36.5 | -15.47 | -25.1 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 3.08 | 3.18 | 2.14 | - | Upgrade
|
| Earnings From Equity Investments | 31.52 | -1.86 | -22.82 | -31.08 | -21.29 | -4.11 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -5.33 | -9.93 | 26.53 | Upgrade
|
| EBT Excluding Unusual Items | 512.43 | 400.42 | 328.06 | 291.65 | 113.61 | 151.71 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.1 | -0.1 | 1.07 | 0.19 | 34.8 | -0.09 | Upgrade
|
| Pretax Income | 512.33 | 400.32 | 329.13 | 291.84 | 148.41 | 151.63 | Upgrade
|
| Income Tax Expense | 13.03 | 14.89 | 33.69 | 16.93 | 13.44 | 4.71 | Upgrade
|
| Earnings From Continuing Operations | 499.3 | 385.42 | 295.44 | 274.91 | 134.97 | 146.92 | Upgrade
|
| Minority Interest in Earnings | -28.35 | -25.3 | -20.98 | -16.31 | -2.98 | - | Upgrade
|
| Net Income | 470.95 | 360.12 | 274.46 | 258.6 | 131.99 | 146.92 | Upgrade
|
| Net Income to Common | 470.95 | 360.12 | 274.46 | 258.6 | 131.99 | 146.92 | Upgrade
|
| Net Income Growth | 44.95% | 31.21% | 6.13% | 95.92% | -10.16% | 3.64% | Upgrade
|
| Shares Outstanding (Basic) | 98 | 97 | 90 | 90 | 86 | 88 | Upgrade
|
| Shares Outstanding (Diluted) | 98 | 97 | 90 | 90 | 86 | 88 | Upgrade
|
| Shares Change (YoY) | 2.30% | 8.16% | - | 4.56% | -1.72% | -2.68% | Upgrade
|
| EPS (Basic) | 4.82 | 3.70 | 3.05 | 2.87 | 1.53 | 1.68 | Upgrade
|
| EPS (Diluted) | 4.82 | 3.70 | 3.05 | 2.87 | 1.53 | 1.68 | Upgrade
|
| EPS Growth | 41.68% | 21.31% | 6.13% | 87.38% | -8.58% | 6.50% | Upgrade
|
| Free Cash Flow | 359.25 | 331.28 | 269.44 | 245.93 | 53.93 | 106.06 | Upgrade
|
| Free Cash Flow Per Share | 3.68 | 3.40 | 2.99 | 2.73 | 0.63 | 1.21 | Upgrade
|
| Dividend Per Share | 0.500 | 1.500 | 2.500 | 1.500 | 0.750 | 1.000 | Upgrade
|
| Dividend Growth | -66.67% | -40.00% | 66.67% | 100.00% | -25.00% | 1.70% | Upgrade
|
| Gross Margin | 35.99% | 34.71% | 34.46% | 35.35% | 33.62% | 35.20% | Upgrade
|
| Operating Margin | 18.30% | 17.21% | 16.81% | 17.17% | 12.00% | 12.33% | Upgrade
|
| Profit Margin | 14.70% | 12.24% | 11.03% | 12.28% | 10.01% | 11.73% | Upgrade
|
| Free Cash Flow Margin | 11.22% | 11.26% | 10.83% | 11.68% | 4.09% | 8.47% | Upgrade
|
| EBITDA | 697.92 | 610.37 | 514.18 | 458.56 | 236.36 | 230.61 | Upgrade
|
| EBITDA Margin | 21.79% | 20.74% | 20.67% | 21.78% | 17.93% | 18.42% | Upgrade
|
| D&A For EBITDA | 111.77 | 103.97 | 95.89 | 97.18 | 78.19 | 76.22 | Upgrade
|
| EBIT | 586.15 | 506.4 | 418.29 | 361.38 | 158.17 | 154.39 | Upgrade
|
| EBIT Margin | 18.30% | 17.21% | 16.81% | 17.17% | 12.00% | 12.33% | Upgrade
|
| Effective Tax Rate | 2.54% | 3.72% | 10.24% | 5.80% | 9.06% | 3.11% | Upgrade
|
| Advertising Expenses | - | 39.82 | 25.92 | 25.84 | 11.15 | 16.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.